Histamin-Kontrollösung Bencard Allergie (Histamine Dihydrochloride)

Histamin‑Kontrollösung Bencard Allergie is used primarily for skin prick testing to identify immediate‑type hypersensitivity reactions.

• Conducting standardized histamine control tests to confirm skin reactivity.
• Comparing patient response to known allergens during allergy work‑up.
• Establishing a positive control in intradermal or prick testing protocols.
• Assisting in the interpretation of wheal size for diagnostic thresholds.
• Supporting research studies that require a reproducible histamine challenge.
• Facilitating training of healthcare professionals in allergy testing techniques.

• Histamine dihydrochloride acts as an agonist at H1 histamine receptors located on cutaneous mast cells and vascular endothelium. Binding to these receptors triggers intracellular signaling that leads to vasodilation, increased vascular permeability, and the formation of a localized wheal and flare response. The controlled reaction provides a measurable reference point for evaluating patient sensitivity to specific allergens during skin prick or intradermal testing.

Local skin reactions are the most frequently reported effects of histamine skin testing solutions. These reactions are generally mild and transient.

Common

• Mild itching or tingling at the test site.
• Small wheal (raised bump) measuring up to 5 mm.
• Redness (erythema) surrounding the wheal.
• Transient swelling that resolves within 30 minutes.

Serious

• Large wheal exceeding 10 mm indicating hyper‑reactivity.
• Prolonged edema lasting more than two hours.
• Systemic urticaria or hives beyond the test area.
• Rare anaphylactic reaction requiring emergency care.

When using Histamin‑Kontrollösung Bencard Allergie, certain precautions help ensure accurate results and patient safety.

• Verify that the patient has not taken antihistamines or mast‑cell stabilizers for at least 48 hours before testing.
• Perform a skin test on a small, non‑hairy area to assess individual sensitivity.
• Avoid testing on inflamed, infected, or damaged skin.
• Document baseline skin condition and any previous reactions to histamine controls.
• Ensure proper storage of the solution according to the manufacturer’s instructions, typically refrigerated and protected from light.
• Use a sterile lancet or needle for each prick to prevent cross‑contamination.

Histamine skin test solutions can interact with other substances that modify histamine pathways or affect skin reactivity.

Avoid

• Concurrent oral or topical antihistamines, which may suppress the wheal response.
• Recent use of corticosteroids applied to the test area, which can diminish skin reactivity.
• Mast‑cell stabilizing agents (e.g., cromolyn) taken within 24 hours.

Use with caution

• Beta‑blockers, which may alter cardiovascular response to histamine.
• ACE inhibitors, as they can enhance vasodilatory effects.
• Tricyclic antidepressants, which may modestly affect histamine metabolism.